BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25796750)

  • 1. [Psoriasis syndrome with its comorbidities].
    Piérard-Franchimont C; Piérard GE; Delvenne P; Hermanns-Lê T
    Rev Med Liege; 2014 Oct; 69(10):555-8. PubMed ID: 25796750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Helper Cell Subsets in Clinical Manifestations of Psoriasis.
    Diani M; Altomare G; Reali E
    J Immunol Res; 2016; 2016():7692024. PubMed ID: 27595115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine network in psoriasis revisited.
    Michalak-Stoma A; Pietrzak A; Szepietowski JC; Zalewska-Janowska A; Paszkowski T; Chodorowska G
    Eur Cytokine Netw; 2011 Dec; 22(4):160-8. PubMed ID: 22236965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual antagonism of T cells causing psoriasis and atopic eczema.
    Eyerich S; Onken AT; Weidinger S; Franke A; Nasorri F; Pennino D; Grosber M; Pfab F; Schmidt-Weber CB; Mempel M; Hein R; Ring J; Cavani A; Eyerich K
    N Engl J Med; 2011 Jul; 365(3):231-8. PubMed ID: 21774711
    [No Abstract]   [Full Text] [Related]  

  • 5. Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis.
    Miyagawa I; Nakayamada S; Nakano K; Kubo S; Iwata S; Miyazaki Y; Yoshikawa M; Yoshinari H; Tanaka Y
    Rheumatology (Oxford); 2019 Feb; 58(2):336-344. PubMed ID: 29618121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-helper 17 cells: the driving force of psoriasis and psoriatic arthritis.
    Yoo IS; Lee JH; Song ST; Kim JH; Lee HJ; Kang SW
    Int J Rheum Dis; 2012 Dec; 15(6):531-7. PubMed ID: 23253236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis and cardiovascular comorbidities with emphasis in Asia.
    Chu TW; Tsai TF
    G Ital Dermatol Venereol; 2012 Apr; 147(2):189-202. PubMed ID: 22481582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psoriasis or atopic eczema: skin-infiltrating effector memory T cells make the difference].
    Homey B
    Hautarzt; 2012 Jan; 63(1):52. PubMed ID: 22212158
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic advances reveal new targets in psoriasis and psoriatic arthritis.
    Mortezavi M; Ritchlin C
    Discov Med; 2015 Oct; 20(110):169-75. PubMed ID: 26562469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity in the pathogenesis of psoriasis.
    Sweeney CM; Tobin AM; Kirby B
    Arch Dermatol Res; 2011 Dec; 303(10):691-705. PubMed ID: 21863252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
    Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
    BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methotrexate monotherapy on T-cell subsets in the peripheral circulation in psoriasis.
    Priyadarssini M; Chandrashekar L; Rajappa M
    Clin Exp Dermatol; 2019 Jul; 44(5):491-497. PubMed ID: 30294828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis.
    Ko JM; Qureshi AW
    G Ital Dermatol Venereol; 2010 Jun; 145(3):393-406. PubMed ID: 20461047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Helper T Cells in Psoriasis.
    Hu P; Wang M; Gao H; Zheng A; Li J; Mu D; Tong J
    Front Immunol; 2021; 12():788940. PubMed ID: 34975883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.
    Karczewski J; Dobrowolska A; Rychlewska-Hańczewska A; Adamski Z
    Autoimmunity; 2016 Nov; 49(7):435-450. PubMed ID: 27050731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
    Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
    Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update in the pathogenesis of psoriatic arthritis].
    González S; Queiro R; Ballina J
    Reumatol Clin; 2012 Mar; 8 Suppl 1():S1-6. PubMed ID: 22285206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of psoriasis.
    Mahajan R; Handa S
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S1-9. PubMed ID: 23974689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.